インフォショップ ホームへ 株式会社グローバルインフォメーション
サイトマップ
その他のカテゴリ

商品カタログ

医療/バイオの調査資料販 MEDINFO.JP

バイオシミラー特集
バイオシミラー特集ページ バイオシミラーに関連したレポートを紹介致します。

Translational Cancer Medicine 公式サイト

Outsourcing Asia Summit 2009 公式サイト

Global Healthcare Congress 2009 公式サイト

BioMedical Asia 2009 公式サイト

China 2009 Pharmaceutical R&D Summit 公式サイト

Drug Discovery & Development of Innovative Therapeutics Japan 2009 公式サイト

Protein Kinase Targets 2009 公式サイト

Structure-Based Drug Design 2009 公式サイト

World Vaccine Congress Asia 2009 公式サイト

World Pharmaceutical Congress 2009 公式サイト

Drug Discovery & Development of Innovative Therapeutics 2009 公式サイト
English Korean Chinese
【 英文市場調査報告書 】

米国の医薬品開発市場における ADME/Tox 試験

U.S. ADME/Tox in Drug Development Markets

商品コード : 27200 Frost & Sullivan
出版日 : 2005/02
発行 : Frost & Sullivan
電話でのお問い合わせ
価格情報
概要 原文目次
※この商品は英文にてご提供いたします。

Research Overview

Complexity of ADME/Tox Restrains Greater Uptake of the Solution

One of the main market challenges is the lack of a technology that is truly reliable for absorption, distribution, metabolism, excretion, and toxicology (ADME/Tox) prediction, despite customers using many technologies simultaneously. Although the business aspect will require market participants to adopt a risk analysis approach, the technical and scientific limitations are likely to impose constraints.

This Frost & Sullivan research service provides an overview of the U.S. ADME/Tox markets. The study has been divided into in vitro, in vivo, and in silico ADME/Tox segments. The research service provides industry challenges to both vendors and consumers as well as offers a SWOT analysis of market dynamics for each market segment. The study enables companies to align their positioning strategies to benefit from the changing markets and obtain maximum return on investment.

Disruptive, Novel Technologies to Find Significant Market Uptake

Although new approaches can generate a spurt in revenue, they could also attract away other parts of the market. For instance, developing newer methods for multiplexing or reducing the number of animals per analysis could help generate more insights or complementary information, possibly at an earlier stage.

"However, it is difficult for novel technologies to break into the in vivo market, because the customers are doing their best to preserve the status quo," states the analyst of the research. "Every assurance by vendors to customers needs to be brought to bear, showing that trends are moving toward widespread acceptance of such technologies, beyond the proof of concept."

Predictive Value of Certain Technologies Needs to Be Proven

Market participants have to sort out another issue of the exact correlation of some methods on humans. Although the processes may closely replicate the respective systems during tests, allowances should be made for complications that might arise in the actual implementation on humans. For example, the range of pH or other environmental conditions is likely to complicate even simple measurements such as solubility, which are necessary for accurate predictions.

Over time, this may result in a shakeout in terms of the technologies that are widely viewed as having predictive value," notes the analyst. "This would result in regulatory guidance or action, and some methods may become obsolete."

1 EXECUTIVE SUMMARY

Executive Summary
Executive Summary

2 TOTAL MARKET

Total Market Overview
Overview of Total ADME Tox Market
Total ADME Tox Market Revenues
List of Acronyms
Market Challenges
ADME Tox Total Market: Manufacture / Vendor Challenges
ADME Tox Total Market: Consumer Challenges
ADME Tox Total Market: Regulatory & Intellectual Property Rights

3 IN VITRO: ADME TOX MARKETS

In Vitro Market Overview
Introduction
Market Engineering Analysis
In Vitro Market Dynamics
SWOT Analysis
Marketing Strategies
Strategic Alliances/Partnerships and Mergers and Acquisitions
In Vitro Competitive Landscape & Market Revenues
In Vitro Competitive Landscape and Market Revenues
Competitive Analysis
Revenue Forecast

4 IN VIVO: ADME TOX MARKETS

In Vivo Market Overview
Introduction
Market Engineering Analysis
In Vivo Market Dynamics
SWOT Analysis
Marketing Strategies
Strategic Alliances/Partnerships and Mergers & Acquisitions
In Vivo Competitive Landscape & Market Revenues
In Vitro Competitive Landscape and Market Revenues
Competitive Analysis
Revenue Forecast

5 IN SILICO: ADME TOX MARKET

In Silico Market Overview
Introduction
Market Engineering Ananlysis
In Silico Market Dynamics
SWOT Analysis
Marketing Strategies
Strategic Alliances/Partnerships and Mergers & Acquisitions
In Silico Competitive Landscape & Market Revenues
In Silico Competitive Landscape and Market Revenues
Competitive Analysis
Revenue Forecast

6 FROST & SULLIVAN AWARDS

Awards
Introduction and Overview
Business Development Strategy Leadership Award
Product Differentiation Leadership Award
Product Innovation Award
Product Line Strategy Leadership Award
Technology Innovation Award
概要 原文目次
※この商品は英文にてご提供いたします。
【 英文市場調査報告書 】
米国の医薬品開発市場における ADME/Tox 試験
U.S. ADME/Tox in Drug Development Markets
出版日 : 2005/02
電話でのお問い合わせ
この商品について問い合わせる
この商品のサンプル(抜粋)を依頼する
価格

※ドル建て価格の商品のお支払いは、為替レート (TTS: 92.38) 換算による円建てのご請求書にて承ります。

US $ 4,450 換算 -> ¥ 411,091 (税抜) Hard Copy & Web Access (Regional License)
US $ 3,950 換算 -> ¥ 364,901 (税抜) Web Access
商品コード : 27200
関連する商品をキーワードで検索する